According to Dahlman Rose, Eastman Chemical Co. EMN reported 3Q10 results of $2.33, slightly ahead of pre-announced guidance of $2.20-$2.30 driven by higher sales volumes, higher capacity utilization, and better than anticipated selling prices that more than offset higher raw material and energy costs.
“4Q should be seasonally weaker with the company providing earnings guidance in the range of $1.40-$1.50, excluding about $20-25 MM of severance charges,” Dahlman Rose writes.
“We maintain our Buy rating but have increased our price target to $88, as we expect reduced earnings volatility and margin growth to drive multiple expansion.”
Eastman Chemical currently trades at $77.44.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in